Author:
Hassanipour Mahsa,Zarisfi Mohammadreza,Ehsani Vahid,Allahtavakoli Mohammad
Funder
Vice Chancellor for Research and Technology, Rafsanjan University of Medical Sciences
Subject
General Pharmacology, Toxicology and Pharmaceutics,General Biochemistry, Genetics and Molecular Biology,General Medicine
Reference38 articles.
1. Acute ischemic stroke: overview of major experimental rodent models, pathophysiology, and therapy of focal cerebral ischemia;Durukan;Pharmacol. Biochem. Behav.,2007
2. Intravenous tissue plasminogen activator for acute ischemic stroke;Chapman;Stroke,2000
3. Recombinant tissue plasminogen activators (rtPA): a review;Gurman;Clin. Pharmacol. Ther.,2015
4. A. Qureshi, R. Pande, S. Kim, R. Hanel, J. Kirmani, A. Yahia, Third generation thrombolytics for the treatment of ischemic stroke, Current opinion in investigational drugs (London, England: 2000) 3(12) (2002) 1729-1732.
5. C.R. Carpenter, S.M. Keim, W.K. Milne, W.J. Meurer, W.G. Barsan, B.E.i.E.M.I. Group, Thrombolytic therapy for acute ischemic stroke beyond three hours, The Journal of emergency medicine 40(1) (2011) 82–92.
Cited by
5 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献